Compass Rose Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$30.2M |
| 2 |
Alibaba
BABA
|
+$22M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$10.8M |
| 4 |
Albemarle Corp Depositary Shares
ALB.PRA
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$29.8M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$21.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 40.6% |
| 2 | Consumer Discretionary | 23.51% |
| 3 | Healthcare | 0% |
Similar funds
Compass Rose Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Compass Rose Asset Management held 10 positions worth $92.3M, down 61% from $239M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Compass Rose Asset Management withdrew a net $143M in Q1 2024, closing 4 positions. Its most notable exit was Pfizer, an estimated $29.8M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 41% of assets, up from 0% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Compass Rose Asset Management opened a new position in Warner Bros worth $27.4M.
- Compass Rose Asset Management's largest Q1 2024 buy was Warner Bros: 3,134,000 shares worth $27.4M.
- Compass Rose Asset Management fully exited Pfizer in Q1 2024, selling an estimated $29.8M.
- Compass Rose Asset Management's ten largest holdings make up 100% of its $92.3M portfolio in Q1 2024.
- Compass Rose Asset Management opened 5 new positions and closed 4 in Q1 2024.
- Compass Rose Asset Management's portfolio value fell 61% quarter-over-quarter to $92.3M.
Based on Compass Rose Asset Management's 13F filing for Q1 2024, filed 15 May 2024.